Waljit Dhillo, Professor in Endocrinology & Metabolism, Consultant Endocrinologist and an NIHR Research Professor at Imperial College London has joined KaNDy Therapeutics as a Scientific and Clinical Advisor.

Waljit Dhillo, Professor in Endocrinology & Metabolism, Consultant Endocrinologist and an NIHR Research Professor at Imperial College London has joined KaNDy Therapeutics as a Scientific and [...]

Professor Waljit Dhillo

Professor Waljit Dhillo Scientific and Clinical Advisor Waljit Dhillo is a Professor in Endocrinology & Metabolism, Consultant Endocrinologist and an NIHR Research Professor. He is Head of [...]

KaNDy Therapeutics presents new compelling data with lead candidate NT-814 at The North American Menopause Society 2018 Annual Meeting

~ Treatment with NT-814 resulted in immediate improvements in bothersome post-menopausal symptoms~ ~ Phase Ib/IIa data showed rapid and significant reductions in the frequency and severity of hot [...]

KaNDy Therapeutics successfully raises £25 million in a Series C financing. Funding to advance a breakthrough non-hormonal treatment for symptoms of the menopause, into a Phase 2b study in Q4 2018

Stevenage, UK, 29 August 2018 – KaNDy Therapeutics, a clinical-stage Women’s Health company, today announces it has successfully closed a Series C financing round, raising £25 million from new US [...]

Jo Craig

Jo Craig Senior Vice President CMC Jo joined KaNDy Therapeutics in August 2018 in a new role created to ensure significant senior CMC leadership for the Company and readiness of NT-814 for Phase [...]

Cookie Notice

Josh Richardson

Josh Richardson Managing Director of Longitude Capital Josh Richardson, MD, is a Managing Director with Longitude Capital. Dr. Richardson currently serves on the boards of Neurana Pharmaceuticals [...]

Contact Us

Please fill out the form to get in touch with us.

Not readable? Change text. captcha txt